Skip to main content
Signal8
Thomas Steffen profile photo

Steffen Thomas

CIK: 0001646396

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ANAVEX LIFE SCIENCES CORP. logo
AVXL

ANAVEX LIFE SCIENCES CORP.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • ANAVEX LIFE SCIENCES CORP. logo
    AVXL

    ANAVEX LIFE SCIENCES CORP.

    Jun 5, 2025
    Exercise(M)
    Direct
    50K shares at avg. $1.76$88K
  • ANAVEX LIFE SCIENCES CORP. logo
    AVXL

    ANAVEX LIFE SCIENCES CORP.

    Jun 5, 2025
    Tax Payment(F)
    Direct
    11.3K shares at avg. $7.75$88K
  • ANAVEX LIFE SCIENCES CORP. logo
    AVXL

    ANAVEX LIFE SCIENCES CORP.

    Mar 31, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    50K shares-

1-3 of 3

About Thomas Steffen

Thomas Steffen (SEC CIK 0001646396) files insider reports with the SEC as Director of ANAVEX LIFE SCIENCES CORP. (AVXL).

Signal8 holds 2 ownership filings by Thomas Steffen, all Form 4s, filed between Apr 2, 2025 and Jun 9, 2025. Those filings report 3 transactions, from Mar 31, 2025 to Jun 5, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Thomas Steffen's filings is in NEW YORK, NY.

Recent filings by Thomas Steffen

  • Jun 5, 2025: Option exercise of AVXL shares (Form 4, code M).
  • Jun 5, 2025: Tax withholding of AVXL shares (Form 4, code F).
  • Mar 31, 2025: Grant or award of AVXL derivative securities (Form 4, code A).

Other insiders filing for ANAVEX LIFE SCIENCES CORP. (AVXL)

How to read Form 4 transaction codes